Education
About Us
Working with TipRanks
Follow Us
Procter & Gamble Health Ltd. (IN:PGHL)
:PGHL
Total Valuation
Procter & Gamble Health Ltd. has a market cap or net worth of ₹96.56B. The enterprise value is ₹101.96B.
Market Cap₹96.56B
Enterprise Value₹101.96B
Share Statistics
Procter & Gamble Health Ltd. has 16,599,382 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,599,382
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Procter & Gamble Health Ltd.’s return on equity (ROE) is 0.47 and return on invested capital (ROIC) is 81.75%.
Return on Equity (ROE)0.47
Return on Assets (ROA)0.32
Return on Invested Capital (ROIC)81.75%
Return on Capital Employed (ROCE)1.09
Revenue Per Employee9.12M
Profits Per Employee2.34M
Employee Count1,336
Asset Turnover1.53
Inventory Turnover3.19
Valuation Ratios
The current PE Ratio of Procter & Gamble Health Ltd. is 31.5. Procter & Gamble Health Ltd.’s PEG ratio is 1.37.
PE Ratio31.5
PS Ratio7.03
PB Ratio15.96
Price to Fair Value15.96
Price to FCF51.22
Price to Operating Cash Flow197.93
PEG Ratio1.37
Income Statement
In the last 12 months, Procter & Gamble Health Ltd. had revenue of 12.18B and earned 2.51B in profits. Earnings per share was 151.33.
Revenue12.18B
Gross Profit8.69B
Operating Income6.33B
Pretax Income3.34B
Net Income2.51B
EBITDA3.62B
Earnings Per Share (EPS)151.33
Cash Flow
In the last 12 months, operating cash flow was 492.20M and capital expenditures -32.30M, giving a free cash flow of 459.90M billion.
Operating Cash Flow492.20M
Free Cash Flow459.90M
Free Cash Flow per Share27.71
Dividends & Yields
Procter & Gamble Health Ltd. pays an annual dividend of ₹45, resulting in a dividend yield of 3.17%
Dividend Per Share₹45
Dividend Yield3.17%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.49
52-Week Price Change12.56%
50-Day Moving Average6.08K
200-Day Moving Average5.73K
Relative Strength Index (RSI)40.91
Average Volume (3m)310.00
Important Dates
Procter & Gamble Health Ltd. upcoming earnings date is Feb 11, 2026, TBA (Confirmed).
Last Earnings DateNov 5, 2025
Next Earnings DateFeb 11, 2026
Ex-Dividend DateAug 22, 2025
Financial Position
Procter & Gamble Health Ltd. as a current ratio of 2.44, with Debt / Equity ratio of 1.00%
Current Ratio2.44
Quick Ratio1.94
Debt to Market Cap<0.01
Net Debt to EBITDA-0.50
Interest Coverage Ratio1.10K
Taxes
In the past 12 months, Procter & Gamble Health Ltd. has paid 832.60M in taxes.
Income Tax832.60M
Effective Tax Rate0.25
Enterprise Valuation
Procter & Gamble Health Ltd. EV to EBITDA ratio is 23.16, with an EV/FCF ratio of 50.14.
EV to Sales6.89
EV to EBITDA23.16
EV to Free Cash Flow50.14
EV to Operating Cash Flow47.70
Balance Sheet
Procter & Gamble Health Ltd. has ₹1.89B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹1.89B billion.
Cash & Marketable Securities₹1.89B
Total Debt₹0.00
Net Cash₹1.89B
Net Cash Per Share₹113.59
Tangible Book Value Per Share₹322.60
Margins
Gross margin is 69.11%, with operating margin of 51.98%, and net profit margin of 20.62%.
Gross Margin69.11%
Operating Margin51.98%
Pretax Margin27.46%
Net Profit Margin20.62%
EBITDA Margin29.73%
EBIT Margin28.17%
Analyst Forecast
The average price target for Procter & Gamble Health Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast3.01%
EPS Growth Forecast22.98%